Based on the overexpression of WT1 in leukemia and most solid cancers (reviewed in [6,7] and its cancer-promoting functions in the tumor stroma [8], WT1 is nowadays considered as an oncogene and attractive candidate for cancer therapy. The gene discussed is WT1; the disease is cancer.